bibliographic entry 5482864 [be/5482864]
https://w3id.org/oc/corpus/be/5482864

is a
content
  • Beatty, GL, O'Dwyer, PJ, Clark, J, Shi, JG, Newton, RC, Schaub, R, Maleski, J, Leopold, L, Gajewski, T. Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral inhibitor of indoleamine 2,3-dioxygenase (IDO1) INCB024360 in patients (pts) with advanced malignancies. 2013 ASCO Annual Meeting, J Clin Oncol, 2013, 31, (suppl; abstr 3025)
references